Jun Zhu

Jun Zhu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
FQFa Qin
Fa Qin
HTHaoyu Tang
Haoyu Tang
YZYong Zhang
Yong Zhang
ZZZhenhua Zhang
Zhenhua Zhang
PHPinge Huang
Pinge Huang
JZJun Zhu
Jun Zhu

7 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
XZXiangbing Zhan
Xiangbing Zhan
JLJun Liu
Jun Liu
HLHuiyun Long
Huiyun Long
JZJun Zhu
Jun Zhu
HTHaoyu Tang
Haoyu Tang
Jia WUJia WU
Jia WU
Bone malignant tumors are metastatic and aggressive, with poor treatment outcomes and prognosis. Rapid and accurate diagnosis is crucial for limb salvage and increasing the survival rate. There is a lack of research on deep learning to segment bone malignant tumor lesions in medical images with complex backgrounds and blurred boundaries. Therefore, we propose a new intelligent auxiliary framework for the medical image segmentation of bone malignant tumor lesions, which consists of a supervised edge-attention guidance segmentation network (SEAGNET). We design a boundary key points selection module to supervise the learning of edge attention in the model to retain fine-grained edge feature information. We precisely locate malignant tumors by instance segmentation networks while extracting feature maps of tumor lesions in medical images. The rich contextual-dependent information in the feature map is captured by mixed attention to better understand the uncertainty and ambiguity of the boundary, and edge attention learning is used to guide the segmentation network to focus on the fuzzy boundary of the tumor region. We implement extensive experiments on real-world medical data to validate our model. It validates the superiority of our method over the latest segmentation methods, achieving the best performance in terms of the Dice similarity coefficient (0.967), precision (0.968), and accuracy (0.996). The results prove the important contribution of the framework in assisting doctors to improve the accuracy of diagnosis and clinical efficiency.

14 November 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
FLFeng Liu
Feng Liu
JZJun Zhu
Jun Zhu
BLBaolong Lv
Baolong Lv
LYLei Yang
Lei Yang
WSWenyan Sun
Wenyan Sun
Jia WUJia WU
Jia WU
One of the most prevalent malignant bone tumors is osteosarcoma. The diagnosis and treatment cycle are long and the prognosis is poor. It takes a lot of time to manually identify osteosarcoma from osteosarcoma magnetic resonance imaging (MRI). Medical image processing technology has greatly alleviated the problems faced by medical diagnoses. However, MRI images of osteosarcoma are characterized by high noise and blurred edges. The complex features increase the difficulty of lesion area identification. Therefore, this study proposes an osteosarcoma MRI image segmentation method (OSTransnet) based on Transformer and U-net. This technique primarily addresses the issues of fuzzy tumor edge segmentation and overfitting brought on by data noise. First, we optimize the dataset by changing the precise spatial distribution of noise and the data-increment image rotation process. The tumor is then segmented based on the model of U-Net and Transformer with edge improvement. It compensates for the limitations of U-semantic Net by using channel-based transformers. Finally, we also add an edge enhancement module (BAB) and a combined loss function to improve the performance of edge segmentation. The method’s accuracy and stability are demonstrated by the detection and training results based on more than 4,000 MRI images of osteosarcoma, which also demonstrate how well the method works as an adjunct to clinical diagnosis and treatment.

4 August 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
LWLuna Wang
Luna Wang
LYLiao Yu
Liao Yu
JZJun Zhu
Jun Zhu
HTHaoyu Tang
Haoyu Tang
FGFangfang GOU
Fangfang GOU
Jia WUJia WU
Jia WU
Osteosarcoma is a bone tumor which is malignant. There are many difficulties when doctors manually identify patients’ MRI images to complete the diagnosis. The osteosarcoma in MRI images is very complex, making its recognition and segmentation resource-consuming. Automatic osteosarcoma area segmentation can solve these problems to a certain extent. However, existing studies usually fail to balance segmentation accuracy and efficiency. They are either sensitive to noise with low accuracy or time-consuming. So we propose an auxiliary segmentation method based on denoising and local enhancement. The method first optimizes the osteosarcoma images, including removing noise using the Edge Enhancement based Transformer for Medical Image Denoising (Eformer) and using a non-parameter method to localize and enhance the tumor region in MRI images. Osteosarcoma was then segmented by Deep Feature Aggregation for Real-Time Semantic Segmentation (DFANet). Our method achieves impressive segmentation accuracy. Moreover, it is efficient in both time and space. It can provide information about the location and extent of the osteosarcoma as a basis for further diagnosis.

18 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
HTHaojun Tang
Haojun Tang
HHHui Huang
Hui Huang
JLJun Liu
Jun Liu
JZJun Zhu
Jun Zhu
FGFangfang GOU
Fangfang GOU
Jia WUJia WU
Jia WU
Osteosarcoma is a malignant tumor derived from primitive osteogenic mesenchymal cells, which is extremely harmful to the human body and has a high mortality rate. Early diagnosis and treatment of this disease is necessary to improve the survival rate of patients, and MRI is an effective tool for detecting osteosarcoma. However, due to the complex structure and variable location of osteosarcoma, cancer cells are highly heterogeneous and prone to aggregation and overlap, making it easy for doctors to inaccurately predict the area of the lesion. In addition, in developing countries lacking professional medical systems, doctors need to examine mass of osteosarcoma MRI images of patients, which is time-consuming and inefficient, and may result in misjudgment and omission. For the sake of reducing labor cost and improve detection efficiency, this paper proposes an Attention Condenser-based MRI image segmentation system for osteosarcoma (OMSAS), which can help physicians quickly locate the lesion area and achieve accurate segmentation of the osteosarcoma tumor region. Using the idea of AttendSeg, we constructed an Attention Condenser-based residual structure network (ACRNet), which greatly reduces the complexity of the structure and enables smaller hardware requirements while ensuring the accuracy of image segmentation. The model was tested on more than 4000 samples from two hospitals in China. The experimental results demonstrate that our model has higher efficiency, higher accuracy and lighter structure for osteosarcoma MRI image segmentation compared to other existing models.

31 October 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
FGFangfang GOU
Fangfang GOU
JLJun Liu
Jun Liu
JZJun Zhu
Jun Zhu
Jia WUJia WU
Jia WU
Histopathological examination is an important criterion in the clinical diagnosis of osteosarcoma. With the improvement of hardware technology and computing power, pathological image analysis systems based on artificial intelligence have been widely used. However, classifying numerous intricate pathology images by hand is a tiresome task for pathologists. The lack of labeling data makes the system costly and difficult to build. This study constructs a classification assistance system (OHIcsA) based on active learning (AL) and a generative adversarial network (GAN). The system initially uses a small, labeled training set to train the classifier. Then, the most informative samples from the unlabeled images are selected for expert annotation. To retrain the network, the final chosen images are added to the initial labeled dataset. Experiments on real datasets show that our proposed method achieves high classification performance with an AUC value of 0.995 and an accuracy value of 0.989 using a small amount of labeled data. It reduces the cost of building a medical system. Clinical diagnosis can be aided by the system’s findings, which can also increase the effectiveness and verifiable accuracy of doctors.